We present a full-term female infant with congenital candidiasis characterized by extensive vesicular and pustular skin lesions associated with pneumonia and severe respiratory distress that appeared during the first hours after birth. The patient was born by cesarean section with no history of rupture of membranes. The mother had a vaginal discharge 3 weeks before delivery. The diagnosis was made by culture of pustular fluid, which grew Candida albicans. Systemic cultures were negative. The infant required a very brief course of conventional mechanical ventilation in spite of impressive and extensive lung infiltrates on the chest radiograph. She made a very quick clinical recovery although it is remarkable that antifungal treatment with amphotericin B was begun very late in her clinical course at the time when she was showing obvious signs of major improvement. Current management guidelines strongly recommend specific therapy for infants with invasive congenital candidiasis or with burn-like extensive dermatitis even without lung involvement. We are not suggesting any change in these recommendations; however, at least in our patient, when amphotericin B was started, she was clearly recovering; it seems possible that her disease although extensive might have experienced an unusual spontaneous regression. This case can provide further insights into this unusual neonatal infection.
INTRODUCTION
Unlike nosocomial systemic candidiasis, which is a common problem in neonatal intensive care units worldwide, congenital candidiasis is a very rare disease reported both in term and preterm infants, with less than 100 cases published in the medical literature. 1 The reasons that explain why the disease is so rare are currently unknown, since even with a high incidence of Candida albicans vaginal infection of 10-35% during pregnancy. 2 It is estimated than less than 1% of women develop chorioamnionitis, which is considered the mechanism for fetal infection. 3 Candida chorioamnioitis has been associated more frequently with preterm labor and intrauterine fetal death than with congenital candidiasis. [4] [5] [6] Intrauterine devices and cervical cerclage are reported as significant risk factors, especially in extremely low birth weight infants. 1, 4, 6 Congenital candidiasis causes a variety of clinical features ranging from a diffuse erythematous skin eruption with or without vesicles and pustules to systemic disease where the lungs are usually affected and the skin may or may not be affected. 1, [6] [7] [8] Although management guidelines have been published, 1 due to the rarity of the disease, firm recommendations are difficult to make, since they are based on anecdotal experience. It has been recognized, however, that full-term infants with congenital candidiasis and skin involvement only, often have a benign clinical course and probably do not require therapy, while in infants with respiratory distress and clinical and laboratory signs of sepsis, systemic antifungal therapy with amphotericin B is recommended. 1 Owing to the often benign and self-limited course in full-term infants, underdiagnosis is likely to occur, so the real incidence of this congenital infection is not well known.
In this report, we describe a full-term infant with congenital candidiasis and discuss clinical and diagnostic features as well as some therapeutic implications, which we think are particularly relevant in this patient, and can provide further insights into this unusual neonatal infection.
CASE REPORT
A full-term, 2540 g female infant was born by cesarean section to a 28-year-old, gravida 4, spontaneous abortions 3, diabetic mother with mild pregnancy-induced hypertension. Membranes were intact at the time of the surgery. She received unspecified vaginal medications for vaginal discharge 3 weeks before delivery in addition to her chronic low-dose insulin therapy. Apgar scores were 6 and 7 at 1 and 5 minutes, respectively.
Since the infant was found vigorous and alert she was allowed to stay with her mother in the same hospital room. After 2 hours, skin eruptions were noticed as well as signs of respiratory distress. Since her respiratory status worsened, ampicillin and amikacin were started and the infant was transferred to our institution 55 hours after birth.
At her arrival, the infant had severe respiratory distress, so she was intubated and placed on conventional mechanical ventilation. Acyclovir was added. Blood and cerebrospinal fluid cultures were taken. The initial chest radiograph showed extensive infiltrates in both lungs, and mild cardiomegaly (Figure 1) .
Her skin showed multiple papules, vesicles, and pustules on an erythematous base, more prominent in abdomen, back, and face. Palms and soles were also affected (Figures 2 and 3 ). Mucous membranes, nails, and scalp were spared.
Her cell blood count showed a total leucocyte count of 22.9 Â 10 9 /l with 63% polymorphonuclear leucocytes, 8% band forms, 27% lymphocytes, and a platelet count of 80 Â 10 9 /l. Blood, cerebrospinal fluid cultures, and VDRL were negative. A Papanicolau staining of a cell scraping from one of the vesicles showed no intranuclear inclusions or giant cells. Another sample, obtained from a pustule, showed numerous yeasts. The culture subsequently grew C. Albicans. Ampicillin, amikacin, and acyclovir were discontinued and amphotericin B was started. The infant very quickly improved. She was successfully extubated after 36 hours of mechanical ventilation, and placed on supplemental oxygen for a few days before weaning her to room air. Platelet count became normal the day after admission.
The infant was discharged after a 2-week course of amphotericin B was completed. A follow-up evaluation was done as an outpatient, in which she was found asymptomatic.
It is important to point out that although the sample from the pustular fluid was taken on the day of admission to our institution, the results were obtained 72 hours later. So antifungal treatment began 6 days after birth, at the time when the infant had already been extubated and with obvious clinical improvement.
DISCUSSION
Congenital candidiasis is a rare disease and as more cases are recognized, additional and important information can be gained for a better understanding of this enigmatic clinical entity.
Congenital candidiasis should be considered in the differential diagnosis of neonatal generalized maculopapular or pustular skin eruptions, along with some other disorders such as Listeria monocytogenes infection, impetigo, chickenpox, herpes virus hominis infection, syphilis, and epidermolysis bullosa. 7 Diagnosis can be confirmed by microscopic examination and culture of the skin lesions. 1, 6 As was the case in our patient as well as in other reports, systemic cultures were negative.
It is usually accepted that the disease is acquired in utero via ascending infection although the exact mechanism of how this may occur is currently unknown. It is noteworthy that most cases have occurred with clinically intact chorioamniotic membranes and our patient was not the exception to this previously reported clinical observation. There is evidence that C. albicans may readily penetrate intact membranes. 1, 7, 9 Although vaginal cultures were not done, the patient's mother had vaginal discharge that could have been caused by Candida. Microscopic examination of the placenta and umbilical cord have been proved to be useful for a quick diagnosis: the finding of white microabscesses is highly suggestive of Candida placentitis, 7, 9, 10 so cooperation between obstetricians and neonatologists is very important for early diagnosis.
Although maternal diabetes is not considered a risk factor for congenital candidiasis, 11 this is not a proven fact and further studies are needed before this condition is discarded.
The mother of our patient had three previous spontaneous abortions, and although recurrent candidal infection is possible, there is no proven association between recurrent abortions and Candida infections.
One of the most striking and surprising features of the clinical course of this infant that we would like to emphasize is that she evidently was in much better clinical condition when antifungal treatment was started. We were surprised that even with such an impressive chest radiograph, the infant recovered very quickly. This fact made us consider retrospectively that, in her case, it seems likely that the infection although affecting large areas of skin and lungs was nevertheless, probably self-limited. The current recommendation is to start antifungal therapy when the disease has systemic involvement or extensive burn-like dermatitis. We are not suggesting any change in these guidelines; however, it is useful to recognize that at least in our patient with invasive fungal infection, the condition might have experienced an unusual spontaneous regression.
An additional issue is the choice of antifungal agent when the physician decides to treat. Given the generally more benign nature of congenital candidiasis, some advocate a shorter course with oral fluconazole instead of the traditional long course of amphotericin B, which requires prolonged venous access. Further studies are needed in this regard. 12 
CONCLUSION
We report a case of Congenital invasive Candidiasis and pneumonia in a full-term infant, who had an uneventful recovery even though the antifungal treatment was started very late in the course of the disease, at the time when the infant was clearly recovering. We think that in our patient, there is a possibility that her disease, although complicated by pneumonia, could have been a self-limited clinical condition. However, due to the uncertainty of this rare form of fungal neonatal infection, the current guidelines should be maintained.
